OmniAb signs Lilly deal with $370 million milestones
OmniAb (NASDAQ:OABI) signed a global collaboration and license agreement with Eli Lilly (NYSE:LLY) covering a new ion channel drug discovery program.
OmniAb (NASDAQ:OABI) signed a global collaboration and license agreement with Eli Lilly (NYSE:LLY) covering a new ion channel drug discovery program.
AMC Robotics (NASDAQ:AMCI) reported Q2 2026 revenue of $937,000, down from $1.4 million, while gross profit increased to $751,000.
Rubico (NASDAQ:RUBI) reported a first-half 2026 net loss of $1.1 million on revenue of $9.7 million, with operating cash flow of $4.1 million.
NRx Pharmaceuticals (NASDAQ:NRXP) reported a first-half 2026 net loss of $18 million versus $23.1 million a year earlier, while cash increased to $26.7 million.
OLB Group (NASDAQ:OLB) reported Q2 2026 revenue of $1.28 million, down 43.6% year-over-year, while its net loss narrowed 50.3% to $1.05 million.
WeTouch Technology (NASDAQ:WETH) reported first-half 2026 revenue of $30.3 million, up 9.4%, while net income increased about 25.5% to $6 million.
Uber Technologies (NYSE:UBER) partnered with Zipline to launch autonomous Uber Eats drone deliveries in the U.S., targeting one million daily deliveries by the end of 2029.
EyePoint (NASDAQ:EYPT) said DURAVYU 2.7mg missed LUGANO’s primary BCVA endpoint against 2mg aflibercept in the full Phase 3 dataset.
Prairie Operating (NASDAQ:PROP) reported Q2 2026 revenue of $98.9 million, up approximately 45% year-over-year, while adjusted EBITDA reached $34 million.
InspireMD (NASDAQ:NSPR) reported Q2 2026 revenue of $1.77 million, down 0.4% year-over-year, while its net loss widened to $14.3 million.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy